JANUMET XR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Sitagliptin Phosphate; Metformin Hydrochloride.
| Product ID | 50090-4411_4af91363-ea59-4586-9fff-5520215b1b25 |
| NDC | 50090-4411 |
| Product Type | Human Prescription Drug |
| Proprietary Name | JANUMET XR |
| Generic Name | Sitagliptin And Metformin Hydrochloride |
| Dosage Form | Tablet, Film Coated, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-02-02 |
| Marketing Category | NDA / NDA |
| Application Number | NDA202270 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE |
| Active Ingredient Strength | 50 mg/1; mg/1 |
| Pharm Classes | Biguanide [EPC],Biguanides [CS],Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2019-07-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-0078 | JANUMET | sitagliptin and metformin hydrochloride |
| 0006-0080 | JANUMET | sitagliptin and metformin hydrochloride |
| 0006-0081 | JANUMET | sitagliptin and metformin hydrochloride |
| 0006-0575 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
| 0006-0577 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
| 50090-4411 | JANUMET | sitagliptin and metformin hydrochloride |
| 50090-5618 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
| 70518-2548 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() JANUMET 78934999 3363805 Live/Registered |
MERCK SHARP & DOHME CORP. 2006-07-21 |
![]() JANUMET 78773912 3374065 Live/Registered |
MERCK SHARP & DOHME CORP. 2005-12-15 |